SERA

Sera Prognostics, Inc. NASDAQ Listed Jul 15, 2021

Healthcare ·Medical - Diagnostics & Research ·US · seraprognostics.com

$1.87

Mkt Cap $71.4M

52w Low $1.37 18.4% of range 52w High $4.09

50d MA $2.05 200d MA $2.80

P/E (TTM) -2.9x

EV/EBITDA -3.9x

P/B 1.2x

Debt/Equity 0.0x

ROE -42.3%

P/FCF -5.3x

RSI (14) —

ATR (14) —

Beta 1.06

50d MA $2.05

200d MA $2.80

Avg Volume 51.9K

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

CIK (SEC)

1534969

Phone

801 990 0520

2749 East Parleys Way · Salt Lake City, UT 84109 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
May 6, 2026	AMC	-0.16	-0.17	-6.2%	1.81	-5.5%	+6.1%	—	—	—	—	—
Mar 18, 2026	AMC	-0.17	-0.16	+5.9%	1.91	-5.8%	-6.3%	+2.8%	-1.1%	+11.5%	-2.0%	—
Nov 13, 2025	AMC	-0.19	-0.16	+15.8%	2.95	-4.1%	+0.3%	+3.4%	+2.0%	+2.6%	-2.2%	—
Aug 6, 2025	AMC	-0.21	-0.16	+23.8%	2.75	-6.9%	-5.5%	-4.6%	-5.6%	-4.7%	+3.1%	—
May 7, 2025	AMC	-0.24	-0.20	+16.7%	2.40	+1.2%	-11.7%	+4.7%	+4.5%	+1.3%	-4.3%	—
Mar 19, 2025	AMC	-0.23	-0.25	-8.7%	4.14	+1.4%	-5.1%	-3.6%	+9.2%	-2.2%	-3.0%	—
Nov 6, 2024	AMC	-0.22	-0.24	-9.1%	8.74	+0.0%	-12.7%	-11.7%	+10.4%	-2.7%	-3.7%	—
Aug 7, 2024	AMC	-0.23	-0.25	-8.7%	7.40	-3.1%	+0.1%	-0.1%	-1.1%	-3.7%	-2.7%	—
May 8, 2024	AMC	-0.23	-0.25	-8.7%	9.30	-1.0%	+5.3%	-5.4%	-1.7%	-8.2%	+1.0%	—
Mar 20, 2024	AMC	-0.25	-0.25	+0.0%	9.02	-3.8%	+3.8%	+6.8%	-8.5%	+3.8%	-0.4%	—
Nov 8, 2023	AMC	-0.30	-0.23	+23.3%	1.97	+1.0%	-7.6%	-7.1%	+4.1%	-1.7%	-2.9%	—
Aug 9, 2023	AMC	-0.34	-0.34	+0.0%	2.52	+0.0%	+3.2%	-2.7%	-8.3%	-6.0%	-6.0%	—
May 10, 2023	AMC	-0.35	-0.34	+2.9%	3.48	-0.3%	+0.6%	-0.9%	-1.2%	+0.6%	-1.7%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Aug 10	Citigroup	Maintains	Neutral → Neutral	—	$2.52	$2.52	+0.0%	+3.2%	-2.7%	-8.3%	-6.0%	-6.0%
Nov 10	Citigroup	Maintains	Neutral → Neutral	—	$1.30	$1.29	-0.8%	+10.8%	+0.0%	-2.8%	+2.1%	+0.0%
Sep 14	Berenberg	Maintains	Buy → Buy	—	$2.04	$2.00	-2.0%	-5.9%	-9.4%	-4.6%	+0.0%	+0.6%
Aug 29	Oppenheimer	Maintains	Outperform → Outperform	—	$2.18	$2.10	-3.7%	-0.5%	+1.8%	-5.0%	-1.4%	-3.4%
Apr 27	Berenberg	Maintains	Buy → Buy	—	$2.23	$2.59	+16.1%	+0.9%	-2.7%	+5.0%	-2.2%	-4.4%
Mar 30	Citigroup	Downgrade	Buy → Neutral	—	$4.05	$3.50	-13.6%	-7.7%	+1.3%	-4.5%	-3.3%	-7.1%
Nov 19	Oppenheimer	Maintains	Outperform → Outperform	—	$10.54	$10.65	+1.0%	+2.5%	-0.1%	+1.4%	+0.5%	+0.0%
Aug 9	Citigroup	Maintains	Buy → Buy	—	$12.89	$12.74	-1.2%	+1.2%	-3.8%	-1.8%	-5.1%	-7.9%
Aug 9	Cowen & Co.	Maintains	Outperform → Outperform	—	$12.89	$12.74	-1.2%	+1.2%	-3.8%	-1.8%	-5.1%	-7.9%
Aug 9	William Blair	Maintains	Outperform → Outperform	—	$12.89	$12.74	-1.2%	+1.2%	-3.8%	-1.8%	-5.1%	-7.9%

Data updated apr 27, 2026 12:46am · Source: massive.com